Albertsons reports fourth-quarter loss after opioid settlement charge

Albertsons posted a nonaccomplishment successful the 4th fourth of fiscal 2025 (Q4 FY25), arsenic a complaint tied to an opioid colony model weighed connected results for the play ended 28 February 2026.

The US nutrient and cause retailer said nett income and different gross for Q4 roseate 7.7% from a twelvemonth earlier to $20.25bn. For the afloat year, gross accrued 3.5% to $83.17bn.

In addition, operating show weakened sharply successful the quarter.

Albertsons recorded an operating nonaccomplishment of $506.7m, compared with an operating income of $276m successful the aforesaid play a twelvemonth earlier.

For the afloat fiscal year, operating income declined 52.9% to $727.6m.

The institution besides moved to a nett nonaccomplishment successful Q4, reporting a nonaccomplishment of $480.8m versus nett income of $171.8m a twelvemonth earlier.

Full-year nett income fell 77.3% to $217.4m.

During the quarter, Albertsons booked a nonaccomplishment of $773.8m, oregon $599.8m aft tax, linked to the opioid colony framework.

The model is intended to resoluteness substantially each opioid-related claims brought oregon that could beryllium brought against the institution by participating states, governmental subdivisions and Native American tribes, according to the company.

The colony covers allegations that the retailer’s pharmacies did not adequately show and forestall the misuse of medicine opioid medicines.

Albertsons Companies CEO Susan Morris said: “Fiscal 2025 was a twelvemonth of disciplined execution and resilience, arsenic we closed the twelvemonth with a coagulated 4th fourth that delivered beardown adjusted EBITDA [earnings earlier interest, taxes, depreciation, and amortisation] contempt meaningful top-line pharmacy-related headwinds.

“Across the afloat year, we remained focused connected gathering a stronger instauration for the future, including investing successful our lawsuit worth proposition, advancing integer and loyalty, and strengthening the capabilities that enactment sustainable, semipermanent growth.”

As of 28 February 2026, Albertsons operated 2,244 retail nutrient and cause stores, including 1,713 in-store pharmacies.

Its property besides included 405 substance centres, 22 organisation centres and 19 manufacturing sites.

For FY26, the institution said it expects identical income to scope from level to a 1% increase.

It projected adjusted EBITDA of $3.85bn to $3.92bn and adjusted nett income per Class A communal stock of $2.22 to $2.32.

Albertsons plans superior expenditure of $2bn to $2.2bn successful FY26.

"Albertsons reports fourth-quarter nonaccomplishment aft opioid colony charge" was primitively created and published by Retail Insight Network, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.